Hospital
Methodist Healthcare - Olive Branch Hospital
Methodist Healthcare - Olive Branch Hospital was paid $18.10M by Medicaid between Jan 2018 and Dec 2024, across 168 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoMETHODIST HEALTHCARE - OLIVE BRANCH HOSPITAL
OLIVE BRANCH, MS 38654
OLIVE BRANCH, MS 38654
33aNPI1912341439assigned 04/26/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.10M
24GClaims461,379
24DCodes billed168
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#25 of 77
Median peer was paid$8.23M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 66,216 | $2.82M | |
| 2019 | 71,001 | $3.09M | |
| 2020 | 57,619 | $2.20M | |
| 2021 | 64,868 | $2.45M | |
| 2022 | 71,515 | $2.73M | |
| 2023 | 77,488 | $2.93M | |
| 2024incomplete | 52,672 | $1.87M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 26,327 | 21,183 | $4.61M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 25,800 | 21,863 | $3.34M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.9% | 9,524 | 7,960 | $1.79M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.8% | 14,397 | 11,439 | $1.23M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 5,054 | 4,240 | $728K |
| G0378 | Hospital observation service, per hour | 3.0% | 4,635 | 3,384 | $548K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 9,572 | 8,181 | $363K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 4,551 | 3,885 | $347K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 3,425 | 2,878 | $290K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.5% | 2,861 | 2,577 | $263K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 5,320 | 4,540 | $246K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 7,939 | 6,616 | $243K |
156 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 11,375 | $240K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 8,856 | $228K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 6,850 | $226K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 6,332 | $182K |
| 80053 | Comprehensive metabolic panel | <1% | 27,975 | $159K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 2,204 | $157K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,685 | $155K |
| 86900 | <1% | 2,895 | $139K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,571 | $138K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 32,881 | $138K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,468 | $137K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,263 | $136K |
| 59025 | Fetal non-stress test | <1% | 1,530 | $133K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 626 | $115K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,443 | $111K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,073 | $99K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,880 | $93K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,388 | $85K |
| 36415 | Collection of venous blood by venipuncture | <1% | 39,596 | $84K |
| 86850 | <1% | 2,844 | $61K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,745 | $61K |
| 87400 | <1% | 3,156 | $61K | |
| 84484 | <1% | 8,014 | $57K | |
| 73560 | <1% | 1,471 | $49K | |
| 74018 | <1% | 1,144 | $47K | |
| 73630 | <1% | 1,251 | $47K | |
| 94644 | <1% | 1,006 | $46K | |
| 93971 | <1% | 1,284 | $44K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 817 | $43K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,045 | $43K |
| 86901 | <1% | 2,890 | $43K | |
| 93017 | <1% | 898 | $41K | |
| 84703 | <1% | 8,466 | $39K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,126 | $35K |
| 83880 | <1% | 2,289 | $34K | |
| 72100 | <1% | 752 | $34K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 527 | $28K |
| 73130 | <1% | 744 | $28K | |
| 83690 | <1% | 6,861 | $27K | |
| 73610 | <1% | 729 | $26K | |
| 87081 | <1% | 4,614 | $26K | |
| 81001 | <1% | 13,700 | $25K | |
| 81025 | <1% | 4,905 | $25K | |
| 84702 | <1% | 2,426 | $23K | |
| 73030 | <1% | 659 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,821 | $20K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,876 | $20K |
| 87040 | <1% | 2,177 | $18K | |
| 83605 | <1% | 3,114 | $16K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,606 | $16K |
| 87634 | <1% | 298 | $16K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 265 | $15K |
| 70486 | <1% | 303 | $15K | |
| 83735 | <1% | 4,678 | $15K | |
| 81003 | <1% | 7,585 | $10K | |
| 73110 | <1% | 269 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,085 | $9K |
| 87807 | <1% | 818 | $9K | |
| 85379 | <1% | 1,807 | $9K | |
| 71250 | <1% | 271 | $8K | |
| 85610 | <1% | 2,248 | $8K | |
| 72040 | <1% | 232 | $8K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 346 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 346 | $8K |
| 70496 | <1% | 132 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,699 | $6K |
| 82962 | <1% | 3,263 | $5K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 64 | $5K |
| 70498 | <1% | 132 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 95 | $5K |
| 80061 | Lipid panel | <1% | 778 | $5K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 76 | $4K |
| 85730 | <1% | 1,242 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,321 | $4K |
| 87077 | <1% | 643 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 67 | $3K |
| 84439 | <1% | 534 | $3K | |
| 76642 | <1% | 96 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 71 | $3K |
| 73502 | <1% | 102 | $3K | |
| 73090 | <1% | 61 | $3K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 45 | $3K |
| 12001 | <1% | 40 | $3K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 43 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 609 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 55 | $2K |
| 73070 | <1% | 42 | $2K | |
| 82570 | <1% | 626 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,897 | $2K |
| 87088 | <1% | 258 | $1K | |
| 73590 | <1% | 30 | $966.00 | |
| 72131 | <1% | 25 | $896.42 | |
| 82550 | <1% | 218 | $778.59 | |
| 84156 | <1% | 400 | $765.56 | |
| 87186 | <1% | 142 | $733.46 | |
| 86140 | <1% | 257 | $671.42 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 28 | $662.05 |
| 76770 | <1% | 15 | $613.25 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $588.64 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,269 | $490.75 |
| 87210 | <1% | 177 | $479.66 | |
| 77066 | Tomosynthesis, mammo | <1% | 14 | $439.51 |
| A9270 | Non-covered item or service | <1% | 4,490 | $367.61 |
| 82565 | <1% | 297 | $277.30 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 16 | $266.06 |
| 85027 | <1% | 79 | $253.42 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 364 | $173.60 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 29 | $159.28 |
| 82248 | <1% | 36 | $117.52 | |
| 99490 | Ccm add 20min | <1% | 25 | $103.93 |
| 90686 | <1% | 13 | $91.29 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 691 | $86.13 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,940 | $68.08 |
| 85652 | <1% | 52 | $61.97 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,663 | $61.48 |
| 82247 | <1% | 15 | $54.24 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 230 | $48.03 |
| 80069 | <1% | 18 | $46.86 | |
| 85045 | <1% | 20 | $46.67 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,827 | $44.18 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,831 | $35.56 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,491 | $29.69 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 378 | $23.52 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 2,281 | $18.54 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,564 | $10.33 |
| J2704 | Injection, propofol, 10 mg | <1% | 947 | $9.36 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 250 | $6.88 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,293 | $5.24 |
| J3490 | Unclassified drugs | <1% | 554 | $1.62 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 119 | $0.76 |
| 96376 | <1% | 1,114 | $0.03 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 161 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 525 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 74 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 592 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 29 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 35 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 20 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 74 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 46 | $0.00 |
| 94760 | 0% | 17 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 20 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 30 | $0.00 |
| C1769 | Guide wire | 0% | 13 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 104 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 734 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 73 | $0.00 |
| 90715 | 0% | 65 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 76 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 311 | $0.00 |
| 94664 | 0% | 167 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 14 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 79 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 14 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 80 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANDERS, KRIS (CFO)